These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32599724)
1. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724 [TBL] [Abstract][Full Text] [Related]
2. The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na Alvarez-Collazo J; López-Requena A; Galán L; Talavera A; Alvarez JL; Talavera K Br J Pharmacol; 2019 Apr; 176(8):1090-1105. PubMed ID: 30650182 [TBL] [Abstract][Full Text] [Related]
3. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant. Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567 [TBL] [Abstract][Full Text] [Related]
4. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients. Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085 [TBL] [Abstract][Full Text] [Related]
5. Eleclazine exhibits enhanced selectivity for long QT syndrome type 3-associated late Na El-Bizri N; Xie C; Liu L; Limberis J; Krause M; Hirakawa R; Nguyen S; Tabuena DR; Belardinelli L; Kahlig KM Heart Rhythm; 2018 Feb; 15(2):277-286. PubMed ID: 29017927 [TBL] [Abstract][Full Text] [Related]
6. Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide. Nagatomo T; January CT; Makielski JC Mol Pharmacol; 2000 Jan; 57(1):101-7. PubMed ID: 10617684 [TBL] [Abstract][Full Text] [Related]
7. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580 [TBL] [Abstract][Full Text] [Related]
8. Lidocaine attenuation testing: An in vivo investigation of putative LQT3-associated variants in the SCN5A-encoded sodium channel. Anderson HN; Bos JM; Kapplinger JD; Meskill JM; Ye D; Ackerman MJ Heart Rhythm; 2017 Aug; 14(8):1173-1179. PubMed ID: 28412158 [TBL] [Abstract][Full Text] [Related]
9. Temperature dependence of early and late currents in human cardiac wild-type and long Q-T DeltaKPQ Na+ channels. Nagatomo T; Fan Z; Ye B; Tonkovich GS; January CT; Kyle JW; Makielski JC Am J Physiol; 1998 Dec; 275(6):H2016-24. PubMed ID: 9843800 [TBL] [Abstract][Full Text] [Related]
10. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study. Miller JA; Moise N; Weinberg SH Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185 [TBL] [Abstract][Full Text] [Related]
13. 18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels. Du YM; Xia CK; Zhao N; Dong Q; Lei M; Xia JH Acta Pharmacol Sin; 2012 Jun; 33(6):752-60. PubMed ID: 22609834 [TBL] [Abstract][Full Text] [Related]
14. Selective block of late currents in the DeltaKPQ Na(+) channel mutant by pilsicainide and lidocaine with distinct mechanisms. Ono K; Kaku T; Makita N; Kitabatake A; Arita M Mol Pharmacol; 2000 Feb; 57(2):392-400. PubMed ID: 10648650 [TBL] [Abstract][Full Text] [Related]
15. Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. Iyer V; Roman-Campos D; Sampson KJ; Kang G; Fishman GI; Kass RS Sci Rep; 2015 Aug; 5():13287. PubMed ID: 26289036 [TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes. Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909 [TBL] [Abstract][Full Text] [Related]
18. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels. Potet F; Beckermann TM; Kunic JD; George AL Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action. Fredj S; Sampson KJ; Liu H; Kass RS Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744 [TBL] [Abstract][Full Text] [Related]
20. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction. Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]